Is an early invasive approach superior to a conservative strategy in patients with acute coronary syndrome?

Interactive Cardiovascular and Thoracic Surgery

Volumn 3, Issue 2, 2004, Pages 363-367

  Nagarajan, Darbhamulla V ^a   Lewis, Philip S ^a   Maguire, Michael ^a   Dunning, Joel ^a,b  

^a STEPPING HILL HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Acute coronary syndrome; Evidence based medicine; Review; Thoracic surgery

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENOXAPARIN; HEPARIN; TIROFIBAN;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EVIDENCE BASED MEDICINE; HEART SURGERY; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; REVASCULARIZATION;

EID: 2442583032     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.icvts.2004.02.004     Document Type: Article

References (13)

1. Dunning J., Prendergast B., Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact Cardiovasc Thorac Surg. 2:2003;405-409
2. Fox K.A., Poole-Wilson P.A., Henderson R.A., Clayton T.C., Chamberlain D.A., Shaw T.R., Wheatley D.J., Pocock S.J. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized intervention trial of unstable angina. Lancet. 360:(9335):2002;743-751
3. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and fast revascularisation during instability in coronary artery disease. Investigators. Lancet 1999 Aug 28; 354(9180): 701-7. Erratum in: Lancet 1999 Oct 23; 354(9188): 1478.
4. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II investigators. Fast revascularisation during instability in coronary artery disease. Lancet. 356:(9223):2000;9-16
5. Lagerqvist B., Husted S., Kontny F., Naslund U., Stahle E., Swahn E., Wallentin L. Fast revascularization during instability in coronary artery disease - II. Investigators. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol. 40:(11):2002;1902-1914
6. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., Braunwald E. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - thrombolysis in myocardial infarction 18 investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:(25):2001;1879-1887
7. Boden W.E., O'Rourke R.A., Crawford M.H., Blaustein A.S., Deedwania P.C., Zoble R.G., Wexler L.F., Kleiger R.E., Pepine C.J., Ferry D.R., Chow B.K., Lavori P.W. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans affairs non-Q-wave infarction strategies in hospital (VANQWISH) trial investigators. N Engl J Med. 338:(25):1998;1785-1792. [Erratum in: N Engl J Med 1998; 339(15): 1091]
8. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in myocardial ischemia. Circulation 1994 Apr; 89(4): 1545-56.
9. Spacek R., Widimsky P., Straka E. Value of first day angiography/ angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicentre randomized trial: the VINO study. Eur Heart J. 23:2002;230-238
10. Michalis L.K., Stroumbis C.S., Pappas K. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery: invasive versus conservative strategy (TRUCS study). Eur Heart J. 23:2000;1909-1910
11. McCullogh P.A., O'Neill W.W., Graham M. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE trial). J Am Coll Cardiol. 32:1998;596-605
12. Madsen J.K., Grande P., Saunamaki K., Thayssen P., Kassis E., Eriksen U., Rasmussen K., Haunso S., Nielsen T.T., Haghfelt T., Fritz-hansen P., Hjelms E., Paulsen P.K., Alstrup P., Arendrup H., Niebuhr-jorgensen U., Andersen L.I. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI) Danish trial in acute myocardial infarction. Circulation. 96:(3):1997;748-755
13. Luchi R.J., Scott S.M., Deupree R.H. Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. N Engl J Med. 316:(16):1987;977-984